PL2082735T3 - Amorficzny arypiprazol i sposób jego wytwarzania - Google Patents

Amorficzny arypiprazol i sposób jego wytwarzania

Info

Publication number
PL2082735T3
PL2082735T3 PL08150576T PL08150576T PL2082735T3 PL 2082735 T3 PL2082735 T3 PL 2082735T3 PL 08150576 T PL08150576 T PL 08150576T PL 08150576 T PL08150576 T PL 08150576T PL 2082735 T3 PL2082735 T3 PL 2082735T3
Authority
PL
Poland
Prior art keywords
preparation
amorphous aripiprazole
aripiprazole
amorphous
preparing
Prior art date
Application number
PL08150576T
Other languages
English (en)
Inventor
Katja Dreyer
Uwe Löffler
Klaus Glänzer
Original Assignee
Helm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39529818&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2082735(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Helm Ag filed Critical Helm Ag
Publication of PL2082735T3 publication Critical patent/PL2082735T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL08150576T 2008-01-23 2008-01-23 Amorficzny arypiprazol i sposób jego wytwarzania PL2082735T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08150576A EP2082735B1 (en) 2008-01-23 2008-01-23 Amorphous Aripiprazole and Process for the Preparation thereof

Publications (1)

Publication Number Publication Date
PL2082735T3 true PL2082735T3 (pl) 2011-05-31

Family

ID=39529818

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08150576T PL2082735T3 (pl) 2008-01-23 2008-01-23 Amorficzny arypiprazol i sposób jego wytwarzania

Country Status (6)

Country Link
EP (1) EP2082735B1 (pl)
AT (1) ATE482691T1 (pl)
DE (1) DE602008002809D1 (pl)
ES (1) ES2353444T3 (pl)
PL (1) PL2082735T3 (pl)
PT (1) PT2082735E (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201000948A1 (tr) * 2010-02-09 2011-08-22 Sanovel İlaç San.Ve Ti̇c.A.Ş. Aripiprazol formülasyonları.
DE102010019416A1 (de) * 2010-05-04 2011-11-10 Stada Arzneimittel Ag Schmelztablette, umfassend ein Triptan oder ein atypisches Neuroleptikum
CN108078941A (zh) * 2018-02-07 2018-05-29 瑞阳制药有限公司 阿立哌唑口崩片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54130587A (en) 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP4310605B2 (ja) 2001-05-25 2009-08-12 大塚製薬株式会社 医薬用組成物
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
AU2003230192A1 (en) 2003-03-21 2004-10-11 Hetero Drugs Limited Novel crystalline forms of aripiprazole
US20060270683A1 (en) 2003-04-25 2006-11-30 Lohray Braj B Polymorphs of aripiprazole
WO2005009990A1 (en) 2003-07-25 2005-02-03 Hetero Drugs Limited Aripiprazole crystalline forms
PL1613598T3 (pl) 2003-12-16 2012-03-30 Teva Pharma Sposób wytwarzania krystalicznych form aripiprazolu
EP1880714A1 (en) * 2006-07-20 2008-01-23 Helm AG Amorphous Aripiprazole and Process for the Preparation thereof

Also Published As

Publication number Publication date
ATE482691T1 (de) 2010-10-15
ES2353444T3 (es) 2011-03-02
EP2082735A1 (en) 2009-07-29
DE602008002809D1 (de) 2010-11-11
EP2082735B1 (en) 2010-09-29
PT2082735E (pt) 2010-10-12

Similar Documents

Publication Publication Date Title
IL238438A (en) 2,2,2-trifluoroacetophenones and a method for preparing them
IL287311A (en) Antibodies and processes for their preparation
PL2271606T3 (pl) Sposób wytwarzania 1,2,3,3,3-pentafluoropropenu-1
EP2352202A4 (en) FUNCTIONAL DEVICE AND METHOD FOR MANUFACTURING THE SAME
PL2259763T3 (pl) Taśma mocująca i pielucha jednorazowa mająca taśmę mocującą, oraz sposób ich wytwarzania
ZA201301726B (en) Crystal 6,7-unsaturated-7-carbamoyl morphinan derivative,and method for producing the same.
AP2011005592A0 (en) Microencapsulate and process for the manufacture thereof.
IL181607A0 (en) Novel process for preparing montelukast and salts thereof
IL209578A0 (en) Halogenated polyilane and thermal process for producing the same
ZA201201222B (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-derivatives,methods for the production thereof and use thereof for treating diseases
EP2132152A4 (en) ARTIFICIAL MARBLE OF VARIOUS MODELS AND METHOD FOR MANUFACTURING THE SAME
IL201248A (en) Polates are marked f 18 and methods for preparing them
ZA200808308B (en) Process for preparing linezolid
MY142981A (en) Process for preparing bismuth oxide, and the apparatus therefor
EP1992723A4 (en) WIRE AND METHOD FOR PRODUCING THE SAME
EP2156827A4 (en) CATAPLASM AND PROCESS FOR PRODUCTION OF CATAPLASM
EP2184378A4 (en) EVAPORATION SOURCE, PROCESS FOR PREPARING AN OPTICAL ELEMENT AND OPTICAL ELEMENT
ZA201000520B (en) Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
PL2082735T3 (pl) Amorficzny arypiprazol i sposób jego wytwarzania
GB2469980A8 (en) Novel napthalimide-benzimidazole hybrids as potential antitumour agents and process for the preparation thereof.
ZA200806978B (en) Process for preparing Human G-CSF
IL217584A (en) Process for the preparation of 4,2-dioxotetrahydroporan-3-carboxylates
ZA200907695B (en) Process for preparing dorzolam ide
ZA201101961B (en) Method for preparing 1,6:2,3-dianhydro-beta-d-mannopyranose
EP2241545A4 (en) OPTICALLY ACTIVE 2,2'-BIPHENOL DERIVATIVE AND PROCESS FOR PRODUCING THE SAME